PRESS RELEASE published on 01/08/2026 at 15:29, 2 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 6.02% ownership in Avadel Pharmaceuticals plc's US$0.01 ordinary shares as of 07-Jan-2026. Details in Form 8.3 for Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Inc. Ownership Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE published on 01/08/2026 at 15:29, 2 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc The Vanguard Group, Inc. discloses 1.67% stake in Bakkavor Group plc. No other party involvement. Details under Rule 8.3 of the Takeover Code The Vanguard Group Rule 8.3 Takeover Code Stake Disclosure Bakkavor Group Plc
PRESS RELEASE published on 01/08/2026 at 15:28, 2 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.93% interest in Just Group plc through 51,191,013 relevant securities. Form 8.3 filing under Takeover Code Form 8.3 Takeover Code Securities Disclosure Vanguard Group Just Group Plc
PRESS RELEASE published on 01/08/2026 at 15:27, 2 months 30 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses 4.97% interest in Unite Group plc. Form 8.3 filing under Takeover Code Form 8.3 Takeover Code Vanguard Group Financial Disclosure Unite Group Plc
BRIEF published on 01/07/2026 at 16:19, 3 months ago The Vanguard Group Unveils JTC plc Stake Financial Transactions Takeover Code Securities Disclosure Vanguard Group JTC Plc
BRIEF published on 01/07/2026 at 16:18, 3 months ago Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Securities Disclosure Vanguard Group Avadel Pharmaceuticals Irish Takeover Code
BRIEF published on 01/07/2026 at 16:18, 3 months ago Vanguard's Disclosure in Greencore Group plc Stake Form 8.3 Takeover Code Securities Disclosure Vanguard Group Greencore Group
BRIEF published on 01/07/2026 at 16:17, 3 months ago The Vanguard Group Discloses Interests in Spire Healthcare Form 8.3 Takeover Code Vanguard Group Spire Healthcare Shareholding
BRIEF published on 01/07/2026 at 16:16, 3 months ago The Vanguard Group Discloses Position in Dowlais Group plc Disclosure Takeover Code Shareholding Vanguard Dowlais Group
BRIEF published on 01/07/2026 at 16:16, 3 months ago The Vanguard Group's Disclosure on Auction Technology Group plc The Vanguard Group Takeover Code Securities Disclosure Stock Purchase Auction Technology Group
Published on 04/07/2026 at 15:00, 1 hour 42 minutes ago Karbon-X Expands Enterprise Climate Platform Through Strategic Partnership with carbon-connect AG
Published on 04/07/2026 at 14:45, 1 hour 57 minutes ago Predictiv AI Introduces Clinical AI Reasoning Platform, Files Patent for Domain-Specific Clinical AI Methodology
Published on 04/07/2026 at 14:40, 2 hours 2 minutes ago bioEnergy Development Inc. Advances Domestic Activated Carbon Production Worth Up to $30 Million Over 5 Years
Published on 04/07/2026 at 14:30, 2 hours 12 minutes ago Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
Published on 04/07/2026 at 14:30, 2 hours 12 minutes ago Sekur Private Data Announces Philip Oakley and Kenneth Rogers as Members of Strategic Advisory Board
Published on 04/07/2026 at 16:32, 10 minutes ago Andera Partners portfolio company, Tubulis, acquired by Gilead, adding a potentially best-in-class antibody-drug conjugate and a next-generation platform to Gilead’s oncology pipeline.
Published on 04/07/2026 at 16:30, 12 minutes ago From Old Channel to New Garden: How Chaoyang’s 'Sakura River' is Dazzling Spring
Published on 04/07/2026 at 15:00, 1 hour 42 minutes ago Amrize Announces Date for First Quarter 2026 Financial Results
Published on 04/07/2026 at 14:55, 1 hour 47 minutes ago Original-Research: Delticom AG (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 04/07/2026 at 14:42, 2 hours ago Evotec to Receive Approx. $100 Million as Part of Tubulis Acquisition
Published on 04/07/2026 at 14:44, 1 hour 58 minutes ago Statement of transactions in own shares from March 30, 2026 to April 2, 2026
Published on 04/07/2026 at 12:00, 4 hours 42 minutes ago Disclosure of shares outstanding and voting rights - 07.04.2026
Published on 04/07/2026 at 08:30, 8 hours 12 minutes ago Edenred achieves CDP “A” rating and joins the ranks of global leaders in climate action
Published on 04/07/2026 at 08:00, 8 hours 42 minutes ago Global Agreement Announced at G7 One Health Summit to Accelerate Access to Diagnostics and Responses to Rising Health Threats
Published on 04/06/2026 at 15:00, 1 day 1 hour ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
